Interactions between δ and μ opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: Studies with SNC80 [(+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl) -3-methoxybenzyl]-N,N-diethylbenzamide] and heroin

Journal of Pharmacology and Experimental Therapeutics

Volumn 314, Issue 1, 2005, Pages 221-231

  Stevenson, Glenn W ^a   Folk, John E ^b   Rice, Kenner C ^b   Negus, S Stevens ^a  

^a MCLEAN HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR AGONIST; DIAMORPHINE; DRUG ADDITIVE; MU OPIATE RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; ASSAY; DOSE RESPONSE; DRUG MECHANISM; DRUG SELF ADMINISTRATION; FEMALE; FOOD PREFERENCE; HEAT; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; SEDATION;

ANALGESICS, OPIOID; ANIMALS; BENZAMIDES; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD; HEAT; HEROIN; MACACA MULATTA; MALE; PAIN MEASUREMENT; PIPERAZINES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 23044473575     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.082685     Document Type: Article

References (43)

1. Adams JU, Tallarida RJ, Geller EB, and Adler MW (1993) Isobolographic superadditivity between δ and μ opioid agonists in the rat depends on the ratio of compounds, the μ agonist and the analgesic assay used. J Pharmacol Exp Ther 266:1261-1267.
2. Bowen CA, Fischer BD, Mello NK, and Negus SS (2002) Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys. J Pharmacol Exp Ther 302:264-273.
3. Brandt MR, Furness MS, Rice KC, Fischer BD, and Negus SS (2001) Studies of tolerance and dependence with the δ-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation. J Pharmacol Exp Ther 299:629-637.
4. Caine SB, Negus SS, and Mello NK (2000) Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions. Psychopharmacology (Berl) 148:41-51.
5. Cheng PY, Liu-Chen LY, and Pickel VM (1997) Dual ultrastructural immunocytochemical labeling of μ and δ opioid receptors in the superficial layers of the rat cervical spinal cord. Brain Res 778:367-380.
6. Dykstra LA, Gmerek DE, Winger G, and Woods JH (1987) κ opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther 242:413-420.
7. Dykstra LA, Granger AL, Allen RM, Zhang X, and Rice KC (2002) Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure. Psychopharmacology (Berl) 163:420-429.
8. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, and Edwards RH (1992) Cloning of a delta opioid receptor by functional expression. Science (Wash DC) 258:1952-1955.
9. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, and Devi LA (2000) Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20:RC110.
10. Griffiths RR, Wurster RM, and Brady JV (1976) Discrete-trial choice procedure: effects of naloxone and methadone on choice between food and heroin. Pharmacol Rev 27:357-365.
11. Griffiths RR, Wurster RM, and Brady JV (1981) Choice between food and heroin: effects of morphine, naloxone and secobarbital. J Exp Anal Behav 35:335-351.
12. Gutstein HB and Akil H (2001) Opioid analgesics, in Goodman & Gilman's The Pharmacological Basis of Therapeutics (Limbird JGHLE ed) pp 569-619, McGraw-Hill Companies, New York.
13. Heyman JS, Vaught JL, Mosberg HI, Haaseth RC, and Porreca F (1989) Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin. Eur J Pharmacol 165:1-10.
14. Jordan BA, Cvejic S, and Devi LA (2000) Opioids and their complicated receptor complexes. Neuropsychopharmacology 23:S5-S18.
15. Killian AK, Bonese K, and Schuster CR (1978) The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey. Drug Alcohol Depend 3:243-251.
16. Lord JA, Waterfield AA, Hughes J, and Kosterlitz HW (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature (Lond) 267:495-499.
17. Mansour A, Fox CA, Akil H, and Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22-29.
18. Mansour A, Khachaturian H, Lewis ME, Akil H, and Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11:308-314.
19. Martin WR, Eades CG, Thompson JA, Huppler RE, and Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphinedependent chronic spinal dog. J Pharmacol Exp Ther 197:517-532.
20. Mello NK, Bree MP, and Mendelson JH (1983) Comparison of buprenorphine and methadone effects on opiate self-administration in primates. J Pharmacol Exp Ther 225:378-386.
21. Mello NK and Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
22. Negus SS (2003) Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with damphetamine and flupenthixol. Neuropsychopharmacology 28:919-931.
23. Negus SS (2004a) Delta opioids and substance abuse, in The Delta Receptor (Chang KJ, Porreca F, and Woods JH eds) pp 401-431, Marcel Dekker, New York.
24. Negus SS (2004b) Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys. Psychopharmacology (Berl) 176:204-213.
25. Negus SS (2005) Interactions between the reinforcing effects of cocaine and heroin in a drug vs. food choice procedure in rhesus monkeys: a dose-addition analysis. Psychopharmacology, in press.
26. Negus SS, Brandt MR, Gatch MB, and Mello NK (2003) Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and betafunaltrexamine. Drug Alcohol Depend 70:17-27.
27. Negus SS, Burke TF, Medzihradsky F, and Woods JH (1993a) Effects of opioid agonists selective for μ, κ and δ opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 267:896-903.
28. Negus SS, Butelman ER, Al Y, and Woods JH (1993b) Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tailwithdrawal procedure in rhesus monkeys. J Pharmacol Exp Ther 266:1355-1363.
29. Negus SS, Butelman ER, Chang KJ, DeCosta B, Winger G, and Woods JH (1994) Behavioral effects of the systemically active δ opioid agonist BW373U86 in rhesus monkeys. J Pharmacol Exp Ther 270:1025-1034.
30. Negus SS, Gatch MB, Mello NK, Zhang X, and Rice K (1998) Behavioral effects of the δ-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther 286:362-375.
31. Negus SS, Mello NK, Lukas SE, and Mendelson JH (1995a) Diurnal patterns of cocaine and heroin self-administration in rhesus monkeys responding under a schedule of multiple daily sessions. Behav Pharmacol 6:763-775.
32. Negus SS, Mello NK, Portoghese PS, Lukas SE, and Mendelson JH (1995b) Role of δ opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 273:1245-1256.
33. O'Brien CP (2001) Drug addiction and drug abuse, in Goodman & Gilman's The Pharmacological Basis of Therapeutics (Limbird JGHLE ed) pp 621-642, McGraw Hill Companies, New York.
34. O'Neill SJ, Collins MA, Pettit HO, McNutt RW, and Chang KJ (1997) Antagonistic modulation between the δ opioid agonist BW373U86 and the μ opioid agonist fentanyl in mice. J Pharmacol Exp Ther 282:271-277.
35. Sheldon RJ, Nunan L, and Porreca F (1989) Differential modulation by [D-Pen2,DPen5] enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected μ agonists in vivo. J Pharmacol Exp Ther 249:462-469.
36. Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, and Negus SS (2003) Opioid interactions in rhesus monkeys: effects of δ + μ and δ + κ agonists on schedulecontrolled responding and thermal nociception. J Pharmacol Exp Ther 307:1054-1064.
37. Su YF, McNutt RW, and Chang KJ (1998) δ-Opioid ligands reverse alfentanil-induced respiratory depression but not antinociception. J Pharmacol Exp Ther 287:815-823.
38. Tallarida RJ (2000) Drug Synergism and Dose-Effect Data Analysis, Chapman & Hall/CRC Press, Boca Raton, FL.
39. Walker EA, Zernig G, and Woods JH (1995) Buprenorphine antagonism of μ opioids in the rhesus monkey tail-withdrawal procedure. J Pharmacol Exp Ther 273:1345-1352.
40. Winger G and Woods JH (2001) The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys. Drug Alcohol Depend 62:181-189.
41. Woolverton WL (1987) Analysis of drug interactions in behavioral pharmacology, in Neurobehavioral Pharmacology (Thompson T, Dews PB, and Barrett JE eds) pp 275-302, Lawrence Erlbaum Associates, Hillsdale, NJ.
42. Woolverton WL and Balster RL (1979) The effects of lithium on choice between cocaine and food in the rhesus monkey. Commun Psychopharmacol 3:309-318.
43. Wurster RM, Griffiths RR, Findley JD, and Brady JV (1977) Reduction of heroin self-administration in baboons by manipulation of behavioral and pharmacological conditions. Pharmacol Biochem Behav 7:519-528.